CATALYST BIOSCIENCES, INC. (27)

Browse by Contract Category

Contracts

Catalyst Biosciences, Inc. Form of Director Indemnification Agreement (Filed With SEC on December 27, 2022)
Business Combination Agreement, dated December 26, 2022, by and among Catalyst Biosciences, Inc., GNI USA, Inc., GNI Group Ltd., GNI Hong Kong Limited, Shanghai Genomics, Inc.,... (Filed With SEC on December 27, 2022)
Asset Purchase Agreement, dated December 26, 2022, by and among Catalyst Biosciences, Inc., GNI Group Ltd., and GNI Hong Kong Limited (Filed With SEC on December 27, 2022)
Amendment to Original Employment Agreement between Seline Miller and Catalyst Biosciences, Inc., effective as of March 29, 2022 (Filed With SEC on April 5, 2022)
License Agreement, dated as of April 15, 2021, by and between SL 2T, LLC and Catalyst Biosciences, Inc (Filed With SEC on November 12, 2021)
Second Amendment to Office Lease, dated July 17, 2020, by and between 611 Gateway Center, L.P. and Catalyst Biosciences, Inc (Filed With SEC on November 5, 2020)
Original Employment Agreement between Seline Miller and Catalyst Biosciences, Inc., dated November 4, 2021 (Filed With SEC on April 5, 2022)
Form of Stock Option Award Agreement (Filed With SEC on March 31, 2022)
Equity Distribution Agreement, dated as of October 15, 2021, between Catalyst Biosciences, Inc. and Piper Sandler & Co (Filed With SEC on October 15, 2021)
Consulting Agreement between Catalyst Biosciences, Inc. and Clinton Musil dated October 13, 2021 (Filed With SEC on October 13, 2021)
Consulting Agreement between Howard Levy and Catalyst Biosciences, Inc., dated August 15, 2021 (Filed With SEC on August 16, 2021)
License Agreement, dated as of April 15, 2021, by and between SL 2T, LLC and Catalyst Biosciences, Inc (Filed With SEC on August 5, 2021)
Original Employment Agreement between Grant Blouse and Catalyst Biosciences, Inc., dated August 27, 2018 (Filed With SEC on July 15, 2021)
Amendment to Original Employment Agreement between Grant Blouse and Catalyst Biosciences, Inc., effective as of July 1, 2021 (Filed With SEC on July 15, 2021)
Form of Stock Option Award Agreement (Filed With SEC on March 4, 2021)
Underwriting Agreement, dated January 26, 2021, by and between Catalyst Biosciences, Inc. and Piper Sandler & Co., as representative of the several Underwriters named therein (Filed With SEC on January 27, 2021)
Offer Letter by and between Clinton Musil and Catalyst Biosciences, Inc. dated June 9, 2020 (Filed With SEC on November 5, 2020)
Amended and Restated Collaboration Agreement, dated May 8, 2020, by and between Mosaic Biosciences, Inc. and Catalyst Biosciences, Inc (Filed With SEC on August 6, 2020)
Underwriting Agreement, dated June 18, 2020, by and between Catalyst Biosciences, Inc. and Raymond James & Associates, Inc., as representative of the several Underwriters named... (Filed With SEC on June 19, 2020)
License and Collaboration Agreement, dated December 18, 2019, by and between Biogen International GMBH and Catalyst Biosciences, Inc (Filed With SEC on February 20, 2020)
Description of Annual Cash Incentive Program (Filed With SEC on February 20, 2020)
Amended and Restated Collaboration Agreement, dated December 18, 2019, by and between Mosaic Biosciences, Inc. and Catalyst Biosciences, Inc (Filed With SEC on February 20, 2020)
Description of Securities (Filed With SEC on February 20, 2020)
Underwriting Agreement, dated February 13, 2020, by and between Catalyst Biosciences, Inc. and Raymond James & Associates, Inc., as representative of the several Underwriters... (Filed With SEC on February 14, 2020)
Cooperation Agreement, effective as of January 13, 2020, between Catalyst Biosciences, Inc. and certain Investors specified therein (Filed With SEC on January 17, 2020)
Clinical Supply Agreement, effective as of October 4, 2019, by and between Catalyst Biosciences, Inc. and Catalent Indiana, LLC (Filed With SEC on October 15, 2019)
Amended and Restated License Agreement, dated December 13, 2018, by and between Catalyst and ISU Abxis (Filed With SEC on March 8, 2019)